Literature DB >> 3289485

Chemotherapy of leprosy.

R C Hastings1, S G Franzblau.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3289485     DOI： 10.1146/annurev.pa.28.040188.001311

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN： 0362-1642            Impact factor:   13.820


× No keyword cloud information.
  6 in total

1.  In vitro and in vivo activities of macrolides against Mycobacterium leprae.

Authors:  S G Franzblau; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

2.  Structure-activity relationships of selected phenazines against Mycobacterium leprae in vitro.

Authors:  S G Franzblau; J F O'Sullivan
Journal:  Antimicrob Agents Chemother       Date:  1988-10       Impact factor: 5.191

Review 3.  Current concepts in the pathogenesis of leprosy. Clinical, pathological, immunological and chemotherapeutic aspects.

Authors:  W M Meyers; A M Marty
Journal:  Drugs       Date:  1991-06       Impact factor: 9.546

4.  In vitro effects of antimicrobial agents on Mycobacterium leprae in mouse peritoneal macrophages.

Authors:  N Ramasesh; J L Krahenbuhl; R C Hastings
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

5.  Structure-activity relationships of tetramethylpiperidine-substituted phenazines against Mycobacterium leprae in vitro.

Authors:  S G Franzblau; K E White; J F O'Sullivan
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

6.  Drug susceptibility testing of Mycobacterium leprae in the BACTEC 460 system.

Authors:  S G Franzblau
Journal:  Antimicrob Agents Chemother       Date:  1989-12       Impact factor: 5.191
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.